
Head of Applied Sciences @GoHumanFirst | she/her
New York
Joined October 2022
- Tweets12
- Following59
- Followers17
- Likes57
Caprice Sassano retweeted
ICON has acquired @GoHumanFirst, a cloud-based technology company supporting #precisionmeasurement in clinical trials. As a result, we’ll support sponsors to accelerate and improve #digitalhealthtechnology selection to optimise protocol design. Learn more: iconplc.com/dht
Caprice Sassano retweeted
In our latest publication in Nature @npjDigitalMed, HumanFirst, @Duke and @UCSF analyze social determinants of health (#SDOH) reporting in clinical trials. Learn more about the team’s findings gohumanfirst.com/posts/utili…
Caprice Sassano retweeted
Exciting to see @GoHumanFirst 's insights on 130+ pharma and biotech companies deploying digital endpoints in @statnews this morning!
The patient-centered revolution is happening. Thanks for the conversation @mariojoze. More details: gohumanfirst.com/posts/digit…
Caprice Sassano retweeted
Just how many pharmaceutical orgs have invested in digital endpoints for their clinical trials? The newly-released analysis from HumanFirst reveals numbers behind the trend. Read the analysis: gohumanfirst.com/posts/digit… #digitalhealth
Caprice Sassano retweeted
Big News! We just launched a first-of-its-kind Precision Measures enterprise platform designed to help #biotech & #pharma accelerate #clinicaltrials. Save time & costs by incorporating patient-centric measures & validated tech into your research. Read more gohumanfirst.com/posts/press…
Caprice Sassano retweeted
I've worked in clinical trial design for 6+ yrs.
Scientists ask me about pain, performance, and fatigue. But until recently:
... never joy or empathy.
ICON CMO @glicholai sat down w/ biotechs who are audaciously developing FDA-endpoints that bend trial paradigms.
Can we measure JOY? Wellness and precision biomarkers converging for objective measures of happiness as a critical missing ingredient of modern health research
forbes.com/sites/greglichola…
Caprice Sassano retweeted
Thanks, @NewYorker! What a thrill
Caprice Sassano retweeted
Tis the season to...
🧘 reflect
✍️ set goals for next year
🎯 plan for big moves to help you reach those goals
Looking for inspiration? Read what it's like to be on the product engineering team at HumanFirst from Giselle and @trulynotjames.
medium.com/elektra-labs/what…
Caprice Sassano retweeted
🎉 HumanFirst 2022 Year in Review 🎉
Another record breaking year in our quest to unlock better research for all humans, sooner!
We are grateful to our extended team of advisors, friends, and Humans who helped us on this journey. A few fun stats...
medium.com/elektra-labs/huma…
Part 3 is here and @c_adansdester knocked it out of the park with real-world examples of leveraging our Measure Ontologies to find precision measures that matter!
It's here! The conclusion to our 3-part blog series that will help you choose from 12,000+ digital measures — in literal minutes.
This week, we walk you through the process of selecting measures that matter using our unique Measure Ontologies: medium.com/elektra-labs/prec…
This week's @GoHumanFirst landscape drop is all about the power of hardware and software composability, and how Atlas can help you compare 600+ technologies to find the right tech to capture your digital measures — check it out on the blog!
What tech stack do you need to compose safe and effective digital measures? (e.g., combining hardware, signal processing, apps, and algorithms)
TLDR; it's *way* more than just picking a device. Learn more from @cesassano in this week's landscape drop.
medium.com/elektra-labs/comp…
Excited to share the first cut of Atlas landscape data focusing on the companies developing DHTs by therapeutic area. Next week's installment: hardware versus software!
More than 600 companies are building digital biomarkers across 13+ therapeutic areas — how do you choose the right one?
Today @cesassano dropped the first of a three-part series highlighting the technology developers crafting digital biomarkers: medium.com/elektra-labs/digi…











